4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001181431-08-068196
Options or other derivatives
- Chief Executive Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kollins John A Chief Executive Officer | 2008-12-16 | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | D: show line 1 in the form |
Loading xslF345X03/rrd226607.xml…